Metraipolis › archive › dc_a97bc99ff599

Drug Persistence of Patients with Inflammatory Bowel Disease Under Biological Treatment in the Pre IL-23 Era in a Tertiary Referral Center in Germany — Europe PMC PMID:41464821

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41464821
DOI: 10.3390/jcm14248918
License (as archived): solo-consultazione
Archived: 2026-11-07T14:25:51.284Z
SHA-256 of the archived text: f0ac8e77d03722fd94ac7dc11033aa4e61f384c6a75c161dc3bd562658777950
Stable URL of this page: https://metraipolis.com/documento/dc_a97bc99ff599

How to cite

Drug Persistence of Patients with Inflammatory Bowel Disease Under Biological Treatment in the Pre IL-23 Era in a Tertiary Referral Center in Germany — Europe PMC PMID:41464821 — Europe PMC (en), https://europepmc.org/article/MED/41464821 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a97bc99ff599 (Metraipolis archive dc_a97bc99ff599, sha256 f0ac8e77d03722fd94ac7dc11033aa4e61f384c6a75c161dc3bd562658777950)

BibTeX

@misc{dca97bc99ff599,
  title = {Drug Persistence of Patients with Inflammatory Bowel Disease Under Biological Treatment in the Pre IL-23 Era in a Tertiary Referral Center in Germany — Europe PMC PMID:41464821},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41464821},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a97bc99ff599; sha256 f0ac8e77d03722fd94ac7dc11033aa4e61f384c6a75c161dc3bd562658777950},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41464821. Agents can read the archived copy with the MCP tool read_document.